News

Published on 26 Feb 2024 on Zacks via Yahoo Finance

Penumbra (PEN) Q4 Earnings Top Estimates, Margins Increase


Article preview image

Penumbra, Inc. PEN reported fourth-quarter 2023 adjusted earnings per share (“EPS”) of 76 cents, which beat the Zacks Consensus Estimate by 7%. The company had recorded an adjusted EPS of 16 cents in the year-ago period.

GAAP EPS was $1.38 per share compared to 10 cents in the prior-year quarter.

For the full year, adjusted earnings were $2.09 per share, compared to the year-ago period’s figure of 16 cents.

NYSE.PEN price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Penumbra's (PEN) New Launch to Enhance Blood Clot Removal

Penumbra, Inc. PEN recently announced the FDA’s clearance and the launch of Lightning Flash 2.0, ...

Zacks via Yahoo Finance 24 Apr 2024

Here's Why You Should Retain Penumbra (PEN) Stock for Now

Penumbra, Inc. PEN is likely to grow in the coming quarters, backed by the strength exhibited in ...

Zacks via Yahoo Finance 8 Apr 2024

Are Penumbra, Inc.'s (NYSE:PEN) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent...

It is hard to get excited after looking at Penumbra's (NYSE:PEN) recent performance, when its sto...

Simply Wall St. via Yahoo Finance 21 Mar 2024

Penumbra (PEN) Gains From Innovation, Mounting Costs Ail

Penumbra PEN is gaining traction in the international markets on strong customer uptake. Yet, an ...

Zacks via Yahoo Finance 6 Mar 2024

Earnings call: Inari Medical reports record revenue and expansion plans

Inari Medical Inc. (NARI) has announced a record revenue of over $493 million for the full year o...

Investing.com 1 Mar 2024

Penumbra (PEN) Q4 Earnings Top Estimates, Margins Increase

Penumbra, Inc. PEN reported fourth-quarter 2023 adjusted earnings per share (“EPS”) of 76 cents, ...

Zacks via Yahoo Finance 26 Feb 2024

Penumbra (PEN) Q4 Earnings Top Estimates, Margins Increase

Free Report) reported fourth-quarter 2023 adjusted earnings per share (“EPS”) of 76 cents, which...

Zacks 26 Feb 2024

Decoding Penumbra Inc (PEN): A Strategic SWOT Insight

Penumbra Inc's innovative medical devices continue to address significant unmet needs in neurovas...

GuruFocus.com via Yahoo Finance 25 Feb 2024

Penumbra, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

It's been a mediocre week for Penumbra, Inc. (NYSE:PEN) shareholders, with the stock dropping 12%...

Simply Wall St. via Yahoo Finance 24 Feb 2024

Earnings call: Penumbra reports robust Q4 growth, aims for global expansion By Investing.com

Penumbra, Inc. (NYSE: NYSE:PEN), a global healthcare company, reported a significant year-over-ye...

Investing.com 23 Feb 2024